Literature DB >> 35064062

Characterization of Epigenomic Alterations in HPV16+ Head and Neck Squamous Cell Carcinomas.

Anders Berglund1, Clarisse Muenyi2, Erin M Siegel3, Abidemi Ajidahun2, Steven A Eschrich1, Denise Wong2, Leah E Hendrick2, Ryan M Putney1, Sungjune Kim4, D Neil Hayes5, David Shibata2.   

Abstract

BACKGROUND: Epigenetic changes associated with human papillomavirus (HPV)-driven tumors have been described; however, HPV type-specific alterations are less well understood. We sought to compare HPV16-specific methylation changes with those in virus-unassociated head and neck squamous cell carcinomas (HNSCC).
METHODS: Within The Cancer Genome Atlas, 59 HPV16+ HNSCC, 238 nonviral HNSCC (no detectable HPV or other viruses), and 50 normal head and neck tissues were evaluated. Significant differentially methylated regions (DMR) were selected, and key associated genes were identified. Partial least squares models were generated to predict HPV16 status in additional independent samples.
RESULTS: HPV infection in HNSCC is associated with type-specific methylomic profiles. Multiple significant DMRs were identified between HPV16+, nonviral, and normal samples. The most significant differentially methylated genes, SYCP2, MSX2, HLTF, PITX2, and GRAMD4, demonstrated HPV16-associated methylation patterns with corresponding alterations in gene expression. Phylogenetically related HPV types (alpha-9 species; HPV31, HPV33, and HPV35) demonstrated a similar methylation profile to that of HPV16 but differed from those seen in other types, such as HPV18 and 45 (alpha-7).
CONCLUSIONS: HNSCC linked to HPV16 and types from the same alpha species are associated with a distinct methylation profile. This HPV16-associated methylation pattern is also detected in cervical cancer and testicular germ cell tumors. We present insights into both shared and unique methylation alterations associated with HPV16+ tumors and may have implications for understanding the clinical behavior of HPV-associated HNSCC. IMPACT: HPV type-specific methylomic changes may contribute to understanding biologic mechanisms underlying differences in clinical behavior among different HPV+ and HPV- HNSCC. ©2022 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35064062      PMCID: PMC8983563          DOI: 10.1158/1055-9965.EPI-21-0922

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.090


  66 in total

1.  Characterization of a human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene.

Authors:  C Takahashi; N Akiyama; T Matsuzaki; S Takai; H Kitayama; M Noda
Journal:  Oncogene       Date:  1996-05-16       Impact factor: 9.867

2.  [Expression and clinicopathological significance of GRAMD4 in hepatocellular carcinoma].

Authors:  Jing Zhang; Kangsheng Tu; Zhenyu Zhou; Xin Zheng; Jie Gao; Yingmin Yao; Qingguang Liu
Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi       Date:  2013-02

Review 3.  Increased radiosensitivity of HPV-positive head and neck cancers: Molecular basis and therapeutic perspectives.

Authors:  Haïtham Mirghani; Furrat Amen; Yungan Tao; Eric Deutsch; Antonin Levy
Journal:  Cancer Treat Rev       Date:  2015-10-13       Impact factor: 12.111

Review 4.  Hypermethylated DNA as a biomarker for colorectal cancer: a systematic review.

Authors:  S L Rasmussen; H B Krarup; K G Sunesen; I S Pedersen; P H Madsen; O Thorlacius-Ussing
Journal:  Colorectal Dis       Date:  2016-06       Impact factor: 3.788

5.  Comprehensive analysis of CpG islands in human chromosomes 21 and 22.

Authors:  Daiya Takai; Peter A Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

6.  Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma.

Authors:  Maria Vassilakopoulou; Margaritis Avgeris; Vamsidhar Velcheti; Vassiliki Kotoula; Theodore Rampias; Kyriakos Chatzopoulos; Christos Perisanidis; Christos K Kontos; Aris I Giotakis; Andreas Scorilas; David Rimm; Clarence Sasaki; George Fountzilas; Amanda Psyrri
Journal:  Clin Cancer Res       Date:  2015-09-25       Impact factor: 12.531

7.  Loss of HLTF function promotes intestinal carcinogenesis.

Authors:  Sumit Sandhu; Xiaoli Wu; Zinnatun Nabi; Mojgan Rastegar; Sam Kung; Sabine Mai; Hao Ding
Journal:  Mol Cancer       Date:  2012-03-27       Impact factor: 27.401

8.  STING activation enhances cetuximab-mediated NK cell activation and DC maturation and correlates with HPV+ status in head and neck cancer.

Authors:  Shanhong Lu; Fernando Concha-Benavente; Gulidanna Shayan; Raghvendra M Srivastava; Sandra P Gibson; Lin Wang; William E Gooding; Robert L Ferris
Journal:  Oral Oncol       Date:  2018-02-20       Impact factor: 5.337

Review 9.  Epigenetics of oropharyngeal squamous cell carcinoma: opportunities for novel chemotherapeutic targets.

Authors:  Cameron Lindsay; Hadi Seikaly; Vincent L Biron
Journal:  J Otolaryngol Head Neck Surg       Date:  2017-01-31

10.  Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers.

Authors:  Mizuo Ando; Yuki Saito; Guorong Xu; Nam Q Bui; Kate Medetgul-Ernar; Minya Pu; Kathleen Fisch; Shuling Ren; Akihiro Sakai; Takahito Fukusumi; Chao Liu; Sunny Haft; John Pang; Adam Mark; Daria A Gaykalova; Theresa Guo; Alexander V Favorov; Srinivasan Yegnasubramanian; Elana J Fertig; Patrick Ha; Pablo Tamayo; Tatsuya Yamasoba; Trey Ideker; Karen Messer; Joseph A Califano
Journal:  Nat Commun       Date:  2019-05-16       Impact factor: 14.919

View more
  3 in total

Review 1.  The Prognostic Role of miR-31 in Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-Analysis with Trial Sequential Analysis.

Authors:  Mario Dioguardi; Francesca Spirito; Diego Sovereto; Mario Alovisi; Riccardo Aiuto; Daniele Garcovich; Vito Crincoli; Luigi Laino; Angela Pia Cazzolla; Giorgia Apollonia Caloro; Michele Di Cosola; Andrea Ballini; Lorenzo Lo Muzio; Giuseppe Troiano
Journal:  Int J Environ Res Public Health       Date:  2022-04-27       Impact factor: 4.614

Review 2.  Epigenetic and Transcriptomic Regulation Landscape in HPV+ Cancers: Biological and Clinical Implications.

Authors:  Rosario Castro-Oropeza; Patricia Piña-Sánchez
Journal:  Front Genet       Date:  2022-06-14       Impact factor: 4.772

3.  Increased expression of SYCP2 predicts poor prognosis in patients suffering from breast carcinoma.

Authors:  Hongyan Zheng; Xiaorong Guo; Nan Li; Luyao Qin; Xiaoqing Li; Ge Lou
Journal:  Front Genet       Date:  2022-09-07       Impact factor: 4.772

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.